A parallel analysis of spleens from tumor-bearing mice showed that CTX treatment was associated with a substantial decrease in B cells frequency overtime and a short-lived (i.e., day 3) depletion of CD4+ and CD8+ T cells (Figure 3A). This evidence concerns the gene CD8A and neoplasm.